Mckesson (MCK) closed at $1079.79 on November 11, 2026, down 0.3% from the previous close, on volume of 388,531 shares (30-day average 716,055).
Data as of November 11, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 2, 2026 | Strangle or Risk Reversal | 15-Dec-281000 P : 1200 C | 600 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 11, 2026. See the 10 largest for 30, 60 and 90 days
Analysts Offer Insights on Healthcare Companies: McKesson (MCK) and Protagonist Therapeutics (PTGX)
TipRanks (Tue, 10-Nov 10:00 AM ET)
J.P. Morgan Keeps Their Buy Rating on McKesson (MCK)
TipRanks (Tue, 10-Nov 7:36 AM ET)
Gabelli Releases Agenda for 8th Annual Healthcare Symposium
Globe Newswire (Mon, 9-Nov 8:00 AM ET)
McKesson Earnings Call Signals Stronger Fiscal 2027
TipRanks (Sat, 7-Nov 7:14 PM ET)
McKesson Reports Fiscal 2027 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
Business Wire (Wed, 4-Nov 4:10 PM ET)
Gabelli To Host 8th Annual Healthcare Symposium
Globe Newswire (Mon, 26-Oct 8:00 AM ET)
McKesson Corporation Declares Quarterly Dividend
Business Wire (Wed, 21-Oct 8:00 AM ET)
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
Business Wire (Tue, 6-Oct 8:00 AM ET)
McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health
Business Wire (Thu, 1-Oct 8:03 AM ET)
McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date
Business Wire (Wed, 23-Sep 8:00 AM ET)
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Mckesson trades on the NYSE stock market under the symbol MCK.
As of November 12, 2026, MCK stock price declined to $1,077.05 with 333,720 million shares trading.
MCK has a beta of -0.31, meaning it tends to be less sensitive to market movements. MCK has a correlation of 0.02 to the broad based SPY ETF.
MCK has a market cap of $125.57 billion. This is considered a Large Cap stock.
Last quarter Mckesson reported $111 billion in Revenue and $11.68 earnings per share. This beat revenue expectation by $971 million and exceeded earnings estimates by $.94.
In the last 3 years, MCK traded as high as $1,121.50 and as low as $431.35.
The top ETF exchange traded funds that MCK belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
MCK has outperformed the market in the last year with a price return of +26.2% while the SPY ETF gained +12.0%. MCK has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +19.5% and +12.1%, respectively, while the SPY returned -1.5% and -2.0%, respectively.
MCK support price is $1,063.38 and resistance is $1,096.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MCK shares will trade within this expected range on the day.
